Frontlight ResearchEarly access
Liver cirrhosis trials in Australia
5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Adelaide, Box Hill, Broadmeadow, Clayton, Coffs Harbour, Devonport, Epping, Heidelberg, Herston, Kingswood, Liverpool, Melbourne, Murdoch, Nedlands, Perth, Westmead
- Age
- 18 years to 80 years
- People
- 2,150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314 - Phase 3Taking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Clayton, Concord, Heidelberg, Kingswood, Liverpool, Parkville, Perth, Westmead
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Adelaide, Fitzroy, Greenslopes, Heidelberg, Herston, Murdoch, Perth, South Brisbane
- Age
- 18 years to 75 years
- People
- 1,800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00 - No phaseTaking peopleLiver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Where
- Heidelberg, Nedlands, Sydney
- Age
- 18 years to 80 years
- People
- 3,000 worldwide
- Run by
- European Foundation for Study of Chronic Liver Failure
See details and how to joinNCT04613921 - No phaseNot yet taking people in AustraliaSafety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
- Where
- Sydney
- Age
- 18 years and over
- People
- 375 worldwide
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT06549673